In the News
Announcement / August 2021
Origami Surgical is pleased to announce the FDA clearance for four new suture materials to our StitchKit® technology platform. These new materials give the surgeon additional flexibility when selecting their suture preference when utilizing StitchKit®.
Press Release / March 2021
Origami Surgical Inc. announces FDA clearance for its next generation StitchKit® robotic platform technology with three new products.
Origami Surgical announces the clearance of their newest technology platform which will provide surgeons with additional StitchKit® devices tailored to meet their specific robotic-assisted suturing needs.
Press Release / October 2020
Origami Surgical Inc. announces FDA clearance of its newest device, StitchKit®PARK™
Madison, NJ, October 9, 2020 –Origami Surgical announced that the FDA has cleared StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice.
For media inquiries, please email us at email@example.com.